niceritrol has been researched along with Coronary Disease in 5 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Niceritrol was administered to 26 patients for 12 weeks at 750 mg/day." | 1.29 | Effect of niceritrol on fibrinolysis and lipoprotein (a) levels in patients with coronary artery disease. ( Imoto, N; Kaikita, K; Miyao, Y; Nishiyama, K; Ogawa, H; Sakamoto, T; Soejima, H; Suefuji, H; Yasue, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujioka, T | 1 |
| Ueno, T | 1 |
| Matsumoto, T | 1 |
| Watanabe, H | 1 |
| Sano, R | 1 |
| Fujino, A | 1 |
| Saito, T | 1 |
| Takenaka, K | 1 |
| Yahata, Y | 1 |
| Ogyu, A | 1 |
| Toyota, T | 1 |
| Suefuji, H | 1 |
| Ogawa, H | 1 |
| Yasue, H | 1 |
| Imoto, N | 1 |
| Sakamoto, T | 1 |
| Miyao, Y | 1 |
| Kaikita, K | 1 |
| Soejima, H | 1 |
| Nishiyama, K | 1 |
| Britov, AN | 1 |
| Shmushkovich, BI | 1 |
| Karmanskiĭ, IM | 1 |
| Itakura, H | 1 |
1 review available for niceritrol and Coronary Disease
| Article | Year |
|---|---|
[Dyslipidemia in renal failure].
Topics: Arteriosclerosis; Cerebrovascular Disorders; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Coronar | 2004 |
4 other studies available for niceritrol and Coronary Disease
| Article | Year |
|---|---|
Reduction by niceritrol treatment of serum lipoprotein(a) in normolipidemic patients with coronary artery disease.
Topics: Adult; Aged; Apolipoproteins; Apolipoproteins B; Cholesterol, LDL; Coronary Disease; Female; Fibrino | 1993 |
Effect of niceritrol on fibrinolysis and lipoprotein (a) levels in patients with coronary artery disease.
Topics: Adult; Aged; Coronary Disease; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Female; Fibri | 1996 |
[Treatment of ischemic heart disease with a hypolipoproteinemic drug pericit].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Drug Evaluation; Female; Humans; Hyperlipidemias; Lipopr | 1977 |
[Treatment of hyperlipidemia].
Topics: Blood Component Removal; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Dieta | 1992 |